Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million, w/population frequency
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million, w/population frequency
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with population frequency information
You May Also Need...
Product Overview
Lonza is your ideal partner when you are looking to buy PBMC. Our Peripheral Blood Mononuclear Cells (PBMCs) are isolated from peripheral blood by apheresis and density gradient separation. Cells are collected from healthy donors following IRB protocols. They are guaranteed to contain ≥50 million viable cells per ampoule. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. A Certificate of Analysis is provided for each cell lot purchased.
Mononuclear cell (MNC) rich cells from leukapheresis are depleted of RBCs and platelets. MNC cell profiles differ by donors and can contain on average around 50% T cells, 20% monocytes, 10% B cells, 10% NK cells and may contain up to 5% granulocytes PBMCs of this part code have added characterization information available with population frequency values for T cells (CD3, CD4, CD8), B cells (CD19), Monocytes (CD14), NK cells (CD56), Dendritic cells (CD11c).
Ability to Screen Different Donors
We maintain an inventory of different donors in an effort to satisfy your sample representation requirements. You can choose a lot based on donor demographic characteristics, and screen multiple lots to find the lot(s) that work best for you. In addition, we can request repeat donors if you need additional cells from a particular donor.
Rich Source of Immune Cells
Peripheral blood mononuclear cells (PBMC) are a mixed population of single nucleus cells. They can be further purified to isolate individual cell types such as natural killer cells, T cells, and B cells. In addition, PMBCs are a rich source of monocytes, which can be directed to differentiate into either macrophages or dendritic cells through culture with various cytokines. Researchers can choose X-Vivo 15 Hematopoeitic media that supports maintenance of lymphocytes and is optimized for serum-free culturing (additional cytokines may be necessary depending on application).
Please contact Scientific Support for serum containing media recommendations. Lonza guarantees the performance of CloneticsTM/PoieticsTM cells only if appropriate CloneticsTM/PoieticsTM media and reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support.
Request More InfoBenefits
- Test negative for mycoplasma, bacteria, yeast, and fungi
- HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots
- Certificate of Analysis (CoA) is provided for each cell lot purchased
Applications
- ELISPOT
- Proliferation assays
- Immunogenicity studies
- Cell therapy process development
- Humanized mice
- Biomarker discovery
- Inflammatory studies
- Immuno-oncology
- CAR-T research
Storage and Content
1 x Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
Educational Material
Brochures, White Papers etc.
-
Procedure for thawing Poietics™ cells
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells. -
Discover the Freshness of Frozen PBMCs
An Assessment of Cryopreservation Impact on T Cell Activation -
Cryopreservation of Peripheral Blood Mononuclear Cells
Does Not Alter Immune Cell Phenotype -
Evaluating Performance of Cryopreserved PBMCs
Quality of Lonza PBMCS in comparison to competitors